“Dupilumab With Concomitant Topical Corticosteroids in Atopic Dermatitis Patients Who Are Inadequately Controlled With or Medically Inadvisable for Cyclosporine A: A Phase 3 Clinical Trial (LIBERTY AD CAFE)”. 2017. SKIN The Journal of Cutaneous Medicine 1 (3.1): s37. https://doi.org/10.25251/skin.1.supp.36.